DaVita (DVA) News Today $105.55 +1.39 (+1.33%) (As of 02:27 PM ET) Add Compare Share Share Today's Range$104.27▼$105.5650-Day Range$73.20▼$106.6152-Week Range$70.80▼$116.97Volume388,868 shsAverage Volume839,346 shsMarket Capitalization$9.64 billionP/E Ratio16.19Dividend YieldN/APrice Target$102.67 HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineBD (BDX) Launches Advanced Vascular Access Management Systemfinance.yahoo.com - December 5 at 3:51 PMDaVita's 'Move It With Purpose' Event Achieves Record-Breaking Participation to Support Life-Saving Caremarkets.businessinsider.com - November 30 at 2:20 PMDaVita Q3 Earnings Transcriptmarketbeat.com - November 28 at 7:01 AMWhy You Should Add DaVita (DVA) Stock to Your Portfoliofinance.yahoo.com - November 22 at 12:43 PMDaVita health tour in Bay Area to provide free kidney screeningsnews.yahoo.com - November 17 at 8:47 PMIs DaVita Inc.'s (NYSE:DVA) ROE Of 30% Impressive?finance.yahoo.com - November 13 at 10:27 AMAll You Need to Know About DaVita HealthCare (DVA) Rating Upgrade to Strong Buyfinance.yahoo.com - November 10 at 4:00 PMDoes DaVita HealthCare (DVA) Have the Potential to Rally 33.24% as Wall Street Analysts Expect?finance.yahoo.com - November 9 at 1:13 PMDaVita Inc. (NYSE:DVA) Q3 2023 Earnings Call Transcriptfinance.yahoo.com - November 8 at 8:36 PMDaVita (DVA) Q3 Earnings & Revenues Top Estimates, Margins Upfinance.yahoo.com - November 8 at 3:36 PMDialysis provider DaVita raises full-year profit outlook, shares risereuters.com - November 7 at 10:42 PMDaVita up ~6% after hours on quarterly results beat, raised profit guidancemsn.com - November 7 at 10:42 PMDaVita (DVA) Q3 2023 Earnings Call Transcriptfinance.yahoo.com - November 7 at 10:42 PMDaVita Inc. Q3 Profit Increases, beats estimatesmarkets.businessinsider.com - November 7 at 5:41 PMDaVita Inc. 3rd Quarter 2023 Resultsfinance.yahoo.com - November 7 at 5:41 PMDaVita Inc. (DVA) Reports Solid Earnings Growth and Robust Cash Flow in Q3 2023finance.yahoo.com - November 7 at 5:41 PMFischbeck’s Sell Rating on DVA amidst Dialysis Rate Update and Market Basket Changesmarkets.businessinsider.com - October 31 at 1:01 AMDaVita: Simple And Compelling After Sell-Offseekingalpha.com - October 26 at 9:46 AMIs AVROBIO (AVRO) Outperforming Other Medical Stocks This Year?finance.yahoo.com - October 23 at 12:42 PMDaVita's (DVA) Latest Partnership to Improve Kidney Carefinance.yahoo.com - October 23 at 12:42 PMDaVita Unusual Options Activity For October 19benzinga.com - October 19 at 1:32 PMDaVita Collaborates with Google Cloud to Develop Customized Clinical Operating System Designed to Transform Kidney Carefinance.yahoo.com - October 18 at 1:02 PMDaVita Inc. Schedules 3rd Quarter 2023 Investor Conference Callfinance.yahoo.com - October 17 at 8:54 PMIs DaVita (DVA) Too Good to Be True? A Comprehensive Analysis of a Potential Value Trapfinance.yahoo.com - October 17 at 3:53 PM3 Must-Buy Warren Buffett Stocks for Volatile Times (DVA)marketbeat.com - October 16 at 1:13 PMTeleflex (TFX) Advances Urology Portfolio With New Buyoutfinance.yahoo.com - October 13 at 6:47 PMThinking about trading options or stock in Tesla, Adobe, Meta Platforms, First Solar, or Davita?benzinga.com - October 12 at 2:39 PMDaVita To Closely Monitor Developments Related To GLP-1smarkets.businessinsider.com - October 12 at 2:39 PMDaVita Unusual Options Activitybenzinga.com - October 12 at 2:39 PMOzempic's early success in kidney trial to have 'limited application' - DaVitanews.yahoo.com - October 12 at 9:38 AMDaVita Statement on GLP-1 and Potential Implications on Chronic Kidney Diseasemarkets.businessinsider.com - October 12 at 9:38 AMDaVita says Ozempic's early success in kidney trial to have 'limited application'reuters.com - October 12 at 9:38 AMOzempic's early success in kidney disease trial drags down dialysis stocksmsn.com - October 11 at 11:57 PMNovo Nordisk Halts Ozempic Kidney Trial. Why It’s Bad for DaVita Stock.barrons.com - October 11 at 6:56 PMDaVita, Fresenius Medical Care, Baxter crushed as Ozempic effective in kidney trialinvesting.com - October 11 at 1:55 PMDialysis Providers Are the Top Decliners in the S&P 500 Wednesdaybarrons.com - October 11 at 1:55 PMWhat's Going On With Kidney Dialysis Provider Stocks Today?msn.com - October 11 at 1:55 PMOzempic Study Shakes Up Market for Kidney and Insulin Treatmentsmsn.com - October 11 at 1:55 PMOzempic's early success in kidney disease trial hits dialysis stocksmsn.com - October 11 at 1:55 PMDaVita stock sell-off over Ozempic study "big overreaction," says UBSmsn.com - October 11 at 1:55 PMDaVita (DVA): A Smart Investment or a Value Trap? An In-Depth Explorationfinance.yahoo.com - October 11 at 1:55 PMOzempic Alert: New Trial Causes DaVita (DVA) Stock to Plunge 20%investorplace.com - October 11 at 1:02 PMDaVita (NYSE:DVA) Shares Gap Down After Analyst Downgrademarketbeat.com - October 11 at 11:35 AMDaVita (NYSE:DVA) Given New $104.00 Price Target at Truist Financialmarketbeat.com - October 11 at 10:15 AMDaVita shares drop amid update on Ozempic kidney failure studymsn.com - October 10 at 7:46 PMUnveiling DaVita Inc (DVA)'s Market Leadership: A Deep Dive into Its Financial Growth and ...finance.yahoo.com - October 10 at 2:46 PMDaVita (NYSE:DVA) sheds 3.3% this week, as yearly returns fall more in line with earnings growthfinance.yahoo.com - October 5 at 5:32 PMDaVita: Continued Economic Hurdles, Market Expectations May Be Correctseekingalpha.com - October 4 at 9:46 PMVeradigm (MDRX) Advances Tie-Up to Enhance Care Deliveryfinance.yahoo.com - October 4 at 4:05 PMDaVita Inc. (NYSE:DVA) Short Interest Updatemarketbeat.com - October 3 at 11:39 AM Get DaVita News Delivered to You Automatically Sign up to receive the latest news and ratings for DVA and its competitors with MarketBeat's FREE daily newsletter. Email Address DVA Media Mentions By Week DVA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DVA News Sentiment▼1.290.50▲Average Medical News Sentiment DVA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DVA Articles This Week▼25▲DVA Articles Average Week Get DaVita News Delivered to You Automatically Sign up to receive the latest news and ratings for DVA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: FMS News Today AGL News Today SHC News Today PGNY News Today QGEN News Today UHS News Today HSIC News Today BRKR News Today BIO.B News Today CRL News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat Originals This page (NYSE:DVA) was last updated on 12/7/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DaVita Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.